Skip to main content
. 2018 Mar 14;33(1):651–656. doi: 10.1080/14756366.2018.1444608

Figure 2.

Figure 2.

Design of the 4-pyrrolidineoxy and 4-piperidineamino substituted quinazolines as PI3Kδ inhibitors.